The immunomodulator LS-2616 (linomide) more effectively than sensitization of the donor enhances graft-versus-host reaction after small bowel transplantation
- 1 March 1994
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 2 (1) , 56-60
- https://doi.org/10.1016/0966-3274(94)90079-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- STIMULATION OF NK CELL, T CELL, AND MONOCYTE FUNCTIONS BY THE NOVEL IMMUNOMODULATOR LINOMIDE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATIONTransplantation, 1992
- PREVENTION OF GRAFT-VERSUS-HOST DISEASE FOLLOWING SMALL BOWEL TRANSPLANTATION WITH POLYCLONAL AND MONOCLONAL ANTILYMPHOCYTE SERUMTransplantation, 1991
- INDUCTION OF GRAFT-VERSUS-HOST DISEASE AND REJECTION BY SENSITIZED SMALL BOWEL ALLOGRAFTSTransplantation, 1991
- EVIDENCE THAT LS-2616 (LINOMIDE) CAUSES ACUTE REJECTION OF RAT ALLOGRAFTS PROTECTED BY CYCLOSPORINE BUT NOT OF LONG-TERM SURVIVING ALLOGRAFTSTransplantation, 1991
- TOTAL ORTHOTOPIC ALLOGENEIC SMALL BOWEL TRANSPLANTATION IN RATSTransplantation, 1989
- ABOLITION OF THE EFFECT OF CYCLOSPORINE ON RAT CARDIAC ALLOGRAFT REJECTION BY THE NEW IMMUNOMODULATOR LS-2616 (LINOMIDE)Transplantation, 1989
- Organ Flush out Solutions and Cold Storage Preservation Solutions: Effect on Organ Cooling and Post Ischemic Erythrocyte Trapping in Kidney GraftsScandinavian Journal of Urology and Nephrology, 1989
- Mechanism of action of the new immunomodulator LS2616 on T cell responsesInternational Journal of Immunopharmacology, 1987
- A novel quinolinecarboxamide with interesting immunomodulatory activityInternational Journal of Immunopharmacology, 1982
- Interleukin-2 augments natural killer cell activityNature, 1981